Skip to main content
Ruben Amarasingham, MD, Internal Medicine, Dallas, TX

Ruben Amarasingham MD


Assistant Professor, Internal Medicine, University of Texas Southwestern

Join to View Full Profile
  • 5123 Harry Hines BlvdPhhs Support Bldg B, Rm G106Dallas, TX 75235

  • Phone+1 214-590-6724

  • Fax+1 214-590-4595

Join Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Ruben Amarasingham, MD is an internist in Dallas, Texas. He is an Assistant Professor at University of Texas Southwestern.

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1999 - 2002
  • University of Texas Southwestern Medical School
    University of Texas Southwestern Medical SchoolClass of 1999

Publications & Presentations

PubMed

Press Mentions

  • Screening for Social Determinants of Health: Active and Passive Information Retrieval Methods
    Screening for Social Determinants of Health: Active and Passive Information Retrieval MethodsNovember 28th, 2022
  • Pieces Debuts GPT-3 Enabled Version of Pieces Predict for US Hospitals
    Pieces Debuts GPT-3 Enabled Version of Pieces Predict for US HospitalsMarch 2nd, 2022
  • Catholic Charities of Pueblo Selects Pieces Connect to Help Them Maximize Their Impact on Children and Families They Serve
    Catholic Charities of Pueblo Selects Pieces Connect to Help Them Maximize Their Impact on Children and Families They ServeMay 24th, 2021
  • Join now to see all

Grant Support

  • FY24 SBIR PHASE IITOPIC NO. 423 PROJECT TITLE: "PASSIVE AND ACTIVE AI SCREENING FOR SOCIAL DETERMINANTS OF HEALTH AND INTERVENTIONS TO IMPROVE OUTCOMES IN THE CANCER PATIENT POPULATION".PIECES TECHNOLOGIES, INC.2024–2026